Autologous hematopoietic stem cell transplantation is superior to alemtuzumab in patients with highly active relapsing multiple sclerosis and severe disability

Autor: Vaisvilas, Mantas, Kaubrys, Gintaras, Kizlaitiene, Rasa, Taluntiene, Vera, Giedraitiene, Natasa
Zdroj: In Multiple Sclerosis and Related Disorders December 2023 80
Databáze: ScienceDirect